Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-14 Sale |
2025-02-18 4:55 pm |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
1,159 | $3.15 | $3,651 | 192,505 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-14 Tax Withholding |
2025-02-18 4:55 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
2,368 | $3.18 | 192,505 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-18 4:55 pm |
N/A 2035-02-13 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
141,200 | $0 | 192,505 (Direct) |
View |
| 2025-02-13 Tax Withholding |
2025-02-18 4:55 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
1,735 | $3.2 | 192,505 (Direct) |
View |
| 2024-11-07 Tax Withholding |
2024-11-12 4:17 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
1,102 | $6.04 | 67,067 (Direct) |
View |
| 2024-11-07 Exercise |
2024-11-12 4:17 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
3,750 | $0 | 67,067 (Direct) |
View |
| 2024-09-16 Tax Withholding |
2024-09-17 5:12 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
661 | $6.36 | 68,169 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-17 5:12 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
2,250 | $0 | 68,169 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-08 7:28 pm |
N/A 2032-01-02 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
115,000 | $0 | 115,000 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 5:03 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
1,735 | $6.53 | 175,130 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-15 5:03 pm |
N/A 2034-02-13 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
150,100 | $0 | 175,130 (Direct) |
View |
| 2023-09-18 Option Award |
2023-09-19 7:23 pm |
N/A 2033-09-17 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2023-08-30 Tax Withholding |
2023-08-31 4:09 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
661 | $2.93 | 43,265 (Direct) |
View |
| 2023-08-30 Exercise |
2023-08-31 4:09 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
2,250 | $0 | 43,265 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 4:45 pm |
N/A 2033-02-12 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
110,000 | $0 | 115,176 (Direct) |
View |
| 2023-01-30 Tax Withholding |
2023-02-01 4:10 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
1,222 | $7.78 | 23,926 (Direct) |
View |
| 2023-01-30 Exercise |
2023-02-01 4:10 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
3,750 | $0 | 23,926 (Direct) |
View |
| 2022-05-26 Tax Withholding(A) |
2022-06-14 4:45 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
1,102 | $7.01 | 2,648 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 4:15 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
3,750 | $0 | 26,250 (Direct) |
View |
Ownership |
2022-03-17 4:18 pm |
N/A 2032-01-02 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
0 | $0 | 141,250 (Direct) |
View |